NF-κB Activity Is Required for the Deregulation of c-myc Expression by the Immunoglobulin Heavy Chain Enhancer
Open Access
- 1 October 2000
- journal article
- Published by Elsevier
- Vol. 275 (41), 32338-32346
- https://doi.org/10.1074/jbc.m004148200
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- A-Myb Up-regulates Bcl-2 through a Cdx Binding Site in t(14;18) Lymphoma CellsPublished by Elsevier ,2000
- Transcriptional Regulation of the Murine 3′ IgH Enhancer by OCT-2Immunity, 1999
- Identification of a homolog of the Cα3′/hs3 enhancer and of an allelic variant of the 3′IgH/hs1,2 enhancer downstream the human immunoglobulin α1 geneEuropean Journal of Immunology, 1997
- Enhancer Complexes Located Downstream of Both Human Immunoglobulin Cα GenesThe Journal of Experimental Medicine, 1997
- Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.Genes & Development, 1994
- A class switch control region at the 3′ end of the immunoglobulin heavy chain locusCell, 1994
- The mouse IgH 3′‐enhancerEuropean Journal of Immunology, 1991
- Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotideThe Lancet, 1990
- A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locusNature, 1990
- Activation and somatic mutation of the translocated c-myc gene in Burkitt lymphoma cellsCell, 1984